| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2007 | CN1309385C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 04/11/2007 | CN1309384C 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity |
| 04/11/2007 | CN1309383C Annelated pyrrole compounds as proton pump inhibitors for treating ulcer |
| 04/11/2007 | CN1309382C 1'-acetoxyl chavicol acetate with anti-HIV activity |
| 04/11/2007 | CN1309381C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/11/2007 | CN1309379C Asari dripping pills and its preparation process |
| 04/11/2007 | CN1309378C Aerosol formulation for inhalation comprising a tiotropium salt |
| 04/11/2007 | CN1309377C Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 04/11/2007 | CN1309374C Improved rapidly disintegratable multiparticulate tablet |
| 04/11/2007 | CN1309370C Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 04/11/2007 | CN1309318C Body building nutrient |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202383 Compounds useful for modulating abnormal cell proliferation |
| 04/10/2007 | US7202381 Compounds as opioid receptor modulators |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202364 ortho-substituted with a fused (hetero)arylamino group, e.g., carboxymethyl 2-(6-chloro-5-indanylamino)phenylacetate; treatment of COX-2 dependent disorders including rheumatoid arthritis, osteoarthritis, dysmenorrhea, pain, tumors or inflammation |
| 04/10/2007 | US7202363 Thienopyridine and furopyridine kinase inhibitors |
| 04/10/2007 | US7202361 Antitumoral ecteinascidin derivatives |
| 04/10/2007 | US7202360 Reacting 2,4-difluorophenyl (4-piperidinyl) methanone oxime hydrochloride and 3-(2-haloethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali solution: high yeild when alkali hydroxide concentration is in the range of 20 to 40% |
| 04/10/2007 | US7202350 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives, are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 04/10/2007 | US7202340 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 04/10/2007 | US7202334 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2007 | US7202282 Microemulsions for selective molecular separation |
| 04/10/2007 | US7202281 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 04/10/2007 | US7202280 Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration |
| 04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202277 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202275 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202272 Treating an endocrine dependent tumor such as breat cancer by administering a chromanone derivative 7-substituted with a sulfamate or sulfate group |
| 04/10/2007 | US7202271 Fused pentacyclic polyethers |
| 04/10/2007 | US7202270 Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses |
| 04/10/2007 | US7202269 GlyT2 modulators |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202265 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 04/10/2007 | US7202264 Supports for oligomer synthesis |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202262 E.g., 3-(5-p-tolyl-[1,2,4]oxadiazol-3-yl)-benzoic acid; translation of mRNA is allowed to continue past a nonsense mutation point, resulting in the production of a full length protein; genetic disorders |
| 04/10/2007 | US7202261 Calcilytic compounds |
| 04/10/2007 | US7202260 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones |
| 04/10/2007 | US7202259 For prophylaxis and therapy of pain or diarrhea in an animal |
| 04/10/2007 | US7202258 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
| 04/10/2007 | US7202256 Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779 |
| 04/10/2007 | US7202255 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same |
| 04/10/2007 | US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections |
| 04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
| 04/10/2007 | US7202252 Xanthines 3-substituted with an arylalkylene or N-heteroarylalkylene group and 8-substituted with a heteroarylalkylene group, e.g. 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(3-pyridyl)methyl]xanthine and 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(4-thiazolyl)methyl]xanthine |
| 04/10/2007 | US7202251 Bicyclic anilide spirohydantoin CGRP receptor antagonists |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202249 Antagonists of chemokine receptors |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules |
| 04/10/2007 | US7202246 Spiro-rifamycin derivatives targeting RNA polymerase |
| 04/10/2007 | US7202245 Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines |
| 04/10/2007 | US7202244 Chk-1 inhibitors |
| 04/10/2007 | US7202243 Substituted imidazotriazines |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202241 8-substituted by an optionally substituted and optionally fused piperidine or piperazine ring and 4 substituted by a (heteo)aryl-methyl-or sulfonyl- group, e.g., 4-(2-Fluoro-benzenesulfonyl)-2,2-dimethyl-8-piperazin-1-yl-3,4-dihydro-2H-benzo[1,4]oxazine; 5-HT6 modulators |
| 04/10/2007 | US7202240 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines |
| 04/10/2007 | US7202239 Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202237 Pyridylether derivatives, their preparation and use |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202235 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for controlling Cryptosporidium parvum disorders such as diarrhea, particularly in immunodeficient individuals |
| 04/10/2007 | US7202234 Compounds and methods for treating Toll-like receptor 2-related diseases and conditions |
| 04/10/2007 | US7202233 Inclusion complex of (a) alprazolam in ring-closed form and (b) a water soluble 2-hydroxypropyl-beta-cyclodextrin, adapted for transmucosal delivery; used for treatment of Generalised Anxiety Disorder |
| 04/10/2007 | US7202232 Acrylonitrile derivatives for inflammation and immune-related uses |
| 04/10/2007 | US7202231 β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 04/10/2007 | US7202230 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity |
| 04/10/2007 | US7202229 Aspirin formulation for cardiovascular health |
| 04/10/2007 | US7202225 Therapeutic delivery compositions and methods of use thereof |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/10/2007 | US7202223 Nucleoside compounds for treating viral infections |
| 04/10/2007 | US7202222 For reducing total weight, and reducing body fat mass |
| 04/10/2007 | US7202221 Macrolides |
| 04/10/2007 | US7202220 Compositions of plant carbohydrates as dietary supplements |
| 04/10/2007 | US7202219 Induces production of butyrate and stimulates the growth of beneficial bacteria in the human colon; useful in food or the like as preventive drug against colon cancer. |
| 04/10/2007 | US7202087 exploits the advantageous properties of lipids as pharmaceutical carriers in regard of gastroinstestinal uptake and/or sustained release and/or convenience and/or economy |
| 04/10/2007 | US7202085 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 04/10/2007 | US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
| 04/10/2007 | US7202040 Method for screening compounds which change the binding properties of a protein with a ligand |
| 04/10/2007 | US7201931 Using plant extracts |
| 04/10/2007 | US7201930 Licorice root extract oral patch for treating canker sores |
| 04/10/2007 | US7201929 A low dose of aspirin (less than about 200mg), vitamin B6, vitamin B12, folic acid, arginine and aged garlic extract; maintaining healthy blood pressure and cholesterol levels |
| 04/10/2007 | US7201926 Synergistic mixture containing limonene and citeonella oil |
| 04/10/2007 | US7201925 Treatment of ungual and subungual diseases |
| 04/10/2007 | US7201924 an aqueous Soma, comprising apple cider vinegar, quinine, blackstrap molasses, sulfur, and whole milk; suited for treating lymphoid malignancies |
| 04/10/2007 | US7201922 Codried granules of lactose and starch with an active substance |
| 04/10/2007 | US7201921 A filling formualtion for soft capsule dosage containing loratadine and derivative, a mixture of mono and diglyceride of medium chain fatty acids, povidone and polyoxyethylene sorbitan fatty ester; capsule material is carrageenan |
| 04/10/2007 | US7201920 Analgesically effective amount of opioid analgesic is combined with polymer to form a matrix |
| 04/10/2007 | US7201919 Mixture for transdermal delivery of low and high molecular weight compounds |
| 04/10/2007 | US7201914 May contain a viricide, a bactericide or bacteriostate, and/or an antiinflammatory agent; uses include control of microbial growth on gloved hands |
| 04/10/2007 | US7201913 Oral formulations for anti-tumor compounds |